To inform approaches to T2D management in other VA Medical Centers nationwide and enhance Veterans’ access to guideline-adherent carbohydrate-restricted nutrition counseling, the LC-CGM program should be evaluated in a larger scale implementation initiative with examination of longer term clinical outcomes and program costs, including use of GLP-1 RAs. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.